TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/17/21 16:15 | 12/15/21 | AMRX | Amneal Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Patel Chirag K. | NJ | DOT | P,Co-CEO | P.m | 626 | 4.17 | 0 | 150 | 41 | 513 | D | |||||||||||||||
5/8/20 19:11 | 5/7/20 | AMRX | Amneal Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Patel Chirag K. | NJ | DOT | P,Co-CEO | M.d | 0 | 0.00 | 0 | 6 | 2 | 363 | D | |||||||||||||||
3/11/20 19:54 | 3/10/20 | AMRX | Amneal Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Patel Chirag K. | NJ | DOT | P,Co-CEO | P | 309 | 3.09 | 0 | 100 | 39 | 356 | D | |||||||||||||||
3/10/20 21:15 | 3/2/20 | AMRX | Amneal Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Patel Chirag K. | NJ | DOT | P,Co-CEO | P.m | 975 | 3.90 | 0 | 250 | 999% | 256 | D | |||||||||||||||
5/8/19 17:45 | 5/8/19 | AMRX | Amneal Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Patel Chirag K. | NJ | DT | M.d | 0 | 0.00 | 0 | 6 | New | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |